{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T05:06:55Z","timestamp":1755925615712},"reference-count":49,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Future Cardiol."],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.2217\/fca.11.17","type":"journal-article","created":{"date-parts":[[2011,5,31]],"date-time":"2011-05-31T17:24:44Z","timestamp":1306862684000},"page":"299-310","source":"Crossref","is-referenced-by-count":5,"title":["Advances in Cardiology: Clinical Trial Update"],"prefix":"10.1080","volume":"7","author":[{"given":"Andrew J","family":"Howe","sequence":"first","affiliation":[{"name":"Craigavon Cardiac Centre Southern Trust\rNorthern Ireland\rBT63 5QQ\rUK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A","family":"Shand","sequence":"additional","affiliation":[{"name":"Craigavon Cardiac Centre Southern Trust\rNorthern Ireland\rBT63 5QQ\rUK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian BA","family":"Menown","sequence":"additional","affiliation":[{"name":"Craigavon Cardiac Centre Southern Trust\rNorthern Ireland\rBT63 5QQ\rUK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2011,5,31]]},"reference":[{"key":"e_1_3_2_3_1_1","unstructured":"Montalescot G : ATOLL: An international randomized trial comparing IV enoxaparin with IV unfractionated heparin in primary PCI for ST-elevation myocardial infarction. Presented at: European Society of Cardiology 2010 Congress. Stockholm Sweden 30 August 2010."},{"key":"e_1_3_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055443"},{"key":"e_1_3_2_3_3_1","unstructured":"Jolly S : FUTURA OASIS 8 a randomized trial comparing two regimens of adjunctive intravenous unfractionated heparin during PCI in high-risk patients with non-STE-ACS treated with fonadaparinux. Presented at: European Society of Cardiology 2010 Congress. Stockholm Sweden 30 August 2010."},{"key":"e_1_3_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq330"},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802944"},{"key":"e_1_3_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq277"},{"key":"e_1_3_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.2217\/bmm.11.4"},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0809171"},{"key":"e_1_3_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.885194"},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61274-3"},{"key":"e_1_3_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1008410"},{"key":"e_1_3_2_3_12_1","unstructured":"Price MJ : Standard versus high-dose clopidogrel according to platelet function testing after PCI: results of the GRAVITAS trial. Presented at: American Heart Association Scientific Sessions 2010. Chicago IL USA 13\u201317 November 2010."},{"key":"e_1_3_2_3_13_1","unstructured":"Connolly S : AVERROES: Apixaban versus acetylsalicylic acid (ASA) to prevent strokes. Presented at: European Society of Cardiology 2010 Congress. Stockholm Sweden 30 August 2010."},{"key":"e_1_3_2_3_14_1","unstructured":"Mahaffey K RocketAF: Efficacy and safety of rivaroxaban for the prevention of stroke in subjects with non-valvular atrial fibrillation. Presented at: American Heart Association Scientific Sessions 2010. Chicago IL USA 13\u201317 November 2010."},{"key":"e_1_3_2_3_15_1","unstructured":"Nielsen J : DANPACE: The Danish multicenter randomized trial on single lead atrial versus dual chamber pacing in sick sinus syndrome. Presented at: European Society of Cardiology 2010 Congress. Stockholm Sweden 30 August 2010."},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00757-5"},{"key":"e_1_3_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907555"},{"key":"e_1_3_2_3_18_1","unstructured":"Yu C -M: Pacing to Avoid Cardiac Enlargement (PACE) study. Presented at: European Society of Cardiology 2010 Congress. Stockholm Sweden 30 August 2010."},{"key":"e_1_3_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1161\/hc4601.099402"},{"key":"e_1_3_2_3_20_1","unstructured":"Goette A ANTIPAF: Angiotensin II antagonist in paroxysmal atrial fibrillation trial. Presented at: European Society of Cardiology 2010 Congress. Stockholm Sweden 30 August 2010."},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0805710"},{"key":"e_1_3_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1735"},{"key":"e_1_3_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61198-1"},{"key":"e_1_3_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009492"},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009540"},{"key":"e_1_3_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1010029"},{"key":"e_1_3_2_3_27_1","unstructured":"Anker SD : Telemedical Interventional Monitoring in Heart Failure (TIM-HF) a randomized controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with chronic heart failure. Presented at: American Heart Association Scientific Sessions 2010. Chicago IL USA 13\u201317 November 2010."},{"key":"e_1_3_2_3_28_1","doi-asserted-by":"crossref","unstructured":"Strauer B : STAR Heart Study: the acute and long-term effect of intracoronary stem cell transplantation in 191 patients with chronic heart failure. Presented at: European Society of Cardiology 2010 Congress. Stockholm Sweden 30 August 2010.","DOI":"10.1093\/eurjhf\/hfq095"},{"key":"e_1_3_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003603"},{"key":"e_1_3_2_3_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a2931"},{"key":"e_1_3_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)03301-5"},{"key":"e_1_3_2_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.02.084"},{"key":"e_1_3_2_3_33_1","unstructured":"Harnek J : EVOLUTION I Study: clinical evaluation of the Edward Lifesciencs percutaneous mitral annuloplasty system for the treatment of mitral regurgitation. Presented at: European Society of Cardiology 2010 Congress. Stockholm Sweden 30 August 2010."},{"key":"e_1_3_2_3_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1008232"},{"key":"e_1_3_2_3_35_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.907402"},{"key":"e_1_3_2_3_36_1","unstructured":"Wendler O : SOURCE registry TAVI: Development of a risk score for transcatheter aortic valve implantation: 1-year outcomes from over 1 000 patients in the SOURCE registry. Presented at: European Society of Cardiology 2010 Congress. Stockholm Sweden 30 August 2010."},{"key":"e_1_3_2_3_37_1","unstructured":"Furlan A : Closure 1 evaluation of the STARFlex\u00ae septal closure system in patients with a stroke or TIA due to the possible passage of a clot of unknown origin through a patent foramen ovale (PFO). Presented at: American Heart Association Scientific Sessions 2010. Chicago IL USA 13\u201317 November 2010."},{"key":"e_1_3_2_3_38_1","unstructured":"Stone G : SPIRIT IV: Two year results from a prospective randomized trial of everolimus eluting stents compared to paclitaxel eluting stents in patients with coronary artery disease. Presented at: Transcatheter Cardiovascular Therapeutics Conference. Washington DC USA 21\u201325 September 2010."},{"key":"e_1_3_2_3_39_1","unstructured":"Kedhi E : COMPARE AMI: Two year outcomes from a prospective randomized trial of everolimus eluting stents compared to paclitaxel eluting stents in patients with STEMI. Presented at: Transcatheter Cardiovascular Therapeutics Conference. Washington DC USA 21\u201325 September 2010."},{"key":"e_1_3_2_3_40_1","unstructured":"Jensen L : SORT OUT 4: a prospective randomized trial of everolimus-eluting and sirolimus eluting stents in patients with coronary artery disease. Presented at: Transcatheter Cardiovascular Therapeutics Conference. Washington DC USA 21\u201325 September 2010."},{"key":"e_1_3_2_3_41_1","unstructured":"Serruys P : Limus eluted from a durable versus erodable stent coating (LEADERS) 3 year results. Presented at: Transcatheter Cardiovascular Therapeutics Conference. Washington DC USA 21\u201325 September 2010."},{"key":"e_1_3_2_3_42_1","unstructured":"Byrne R : Efficacy study of rapamycin- vs. zotarolimus-eluting stents to reduce coronary restenosis (ISAR-TEST-5). Presented at: Transcatheter Cardiovascular Therapeutics Conference. Washington DC USA 21\u201325 September 2010."},{"key":"e_1_3_2_3_43_1","unstructured":"Wohrle J : The PERFECT STENT study: a prospective randomized trial evaluating a paclitaxel eluting balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease. Presented at: Transcatheter Cardiovascular Therapeutics Conference. Washington DC USA 21\u201325 September 2010."},{"key":"e_1_3_2_3_44_1","unstructured":"Chevalier B : CRISTAL: A prospective randomized trial of sirolimus eluting stents compared to balloon angioplasty for restenosis of drug eluting stents. Presented at: Transcatheter Cardiovascular Therapeutics Conference. Washington DC USA 21\u201325 September 2010."},{"key":"e_1_3_2_3_45_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.962423"},{"key":"e_1_3_2_3_46_1","unstructured":"Columbo A : Angiography Versus (vs) IVUS Optimization (AVIO). Presented at: Transcatheter Cardiovascular Therapeutics Conference. Washington DC USA 21\u201325 September 2010."},{"key":"e_1_3_2_3_47_1","doi-asserted-by":"publisher","DOI":"10.2217\/bmm.11.6"},{"key":"e_1_3_2_3_48_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161206776361318"},{"key":"e_1_3_2_4_2_1","unstructured":"Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI) http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00910299"}],"container-title":["Future Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fca.11.17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T02:19:51Z","timestamp":1715998791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fca.11.17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["10.2217\/fca.11.17"],"URL":"https:\/\/doi.org\/10.2217\/fca.11.17","relation":{},"ISSN":["1479-6678","1744-8298"],"issn-type":[{"value":"1479-6678","type":"print"},{"value":"1744-8298","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}